Abbott Laboratories v. Geneva Pharmaceuticals, Inc.

528 U.S. 1078, 120 S. Ct. 796, 145 L. Ed. 2d 671, 68 U.S.L.W. 3430, 2000 U.S. LEXIS 169
CourtSupreme Court of the United States
DecidedJanuary 10, 2000
DocketNo. 99-753
StatusPublished
Cited by4 cases

This text of 528 U.S. 1078 (Abbott Laboratories v. Geneva Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Abbott Laboratories v. Geneva Pharmaceuticals, Inc., 528 U.S. 1078, 120 S. Ct. 796, 145 L. Ed. 2d 671, 68 U.S.L.W. 3430, 2000 U.S. LEXIS 169 (2000).

Opinion

C. A. Fed. Cir. Certiorari denied.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Valley Drug Company v. Geneva Pharmaceuticals, Inc.
344 F.3d 1294 (Eleventh Circuit, 2003)
Scaltech, Inc. v. Retec/tetra, LLC, Defendant-Cross
269 F.3d 1321 (Federal Circuit, 2001)
Honeywell International Inc. v. Hamilton Sundstrand Corp.
166 F. Supp. 2d 1008 (D. Delaware, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
528 U.S. 1078, 120 S. Ct. 796, 145 L. Ed. 2d 671, 68 U.S.L.W. 3430, 2000 U.S. LEXIS 169, Counsel Stack Legal Research, https://law.counselstack.com/opinion/abbott-laboratories-v-geneva-pharmaceuticals-inc-scotus-2000.